Navigating the Management of Hepatitis C 

Supplement Editor:
William Carey, MD
The Cleveland Clinic

Special Edition
September 2003

Supplement 4 to Volume 70

This publication is supported by an unrestricted educational grant from Roche Laboratories Inc.

This supplement was developed
in print form as a certified CME activity. To complete the activity for free CME credit, please request a free print copy of the supplement by
e-mailing dunaskk@ccf.org.

Guidelines for grant-supported supplements  to the
Cleveland Clinic Journal
of Medicine

 

 

 

 

 

 

 

 

 

Education Home | CCF Home | CCJM Home

The Cleveland Clinic Foundation
Cleveland Clinic Journal of Medicine
9500 Euclid Avenue, NA32
Cleveland, Ohio 44195

216.444.2661, FAX 216.444.9385
  ccjm@ccf.org

 

CONTENTS and FACULTY

The epidemiology and natural history of hepatitis C virus infection..........S2
NIZAR N. ZEIN, MD
Consultant, Department of Gastroenterology and Hepatology,
The Cleveland Clinic Foundation, Cleveland, Ohio

Tests and screening strategies for the diagnosis of hepatitis C.....................S7
WILLIAM CAREY, MD
Consultant, Department of Gastroenterology and Hepatology,
The Cleveland Clinic Foundation, Cleveland, Ohio;
Professor of Medicine, Ohio State University

Management of newly diagnosed hepatitis C virus infection......................S14
MARK W. RUSSO, MD, MPH
Assistant Professor of Medicine, University of North Carolina, Chapel Hill
STEVEN L. ZACKS, MD, MPH
Assistant Professor of Medicine, University of North Carolina, Chapel Hill
MICHAEL W. FRIED, MD
Associate Professor of Medicine and Director of Clinical Hepatology,
University of North Carolina, Chapel Hill

Treatment options for nonresponders and relapsers to..............................S21
initial therapy for hepatitis C

MARTEN DUNCAN, DO
Gastroenterology Fellow, Walter Reed Army Medical Center, Washington, D.C., and
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va.
ZOBAIR YOUNOSSI, MD
Director, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va.

Special management challenges in hepatitis C..............................................S27
JOSE MARTAGON, MD
Fellow, Department of Infectious Disease,
The Cleveland Clinic Foundation, Cleveland, Ohio
STEVEN M. GORDON, MD
Hospital Epidemiologist, Department of Infectious Disease,
The Cleveland Clinic Foundation, Cleveland, Ohio


Topics and editors for supplements to the Cleveland Clinic Journal of Medicine are determined by the Journal’s editor-in-chief and staff. Supplement editors are chosen for their expertise in the topics discussed and are responsible for the scientific quality of supplements, including the review process.The Journal ensures that supplement editors and authors fully disclose any relationships with industry, including the supplement underwriter. For full guidelines on grant-supported supplements to the Journal, go to www.ccjm.org/pdffiles/guidelines.pdf.
 

Copyright© 2003 by the Cleveland Clinic Educational Foundation.

The statements and opinions expressed in this supplement to the Cleveland Clinic Journal of Medicine are those of the authors and not necessarily of the Cleveland Clinic Foundation, its Board of Trustees, or Roche Laboratories Inc.

The Cleveland Clinic Journal of Medicine (ISSN 0891-1150) is published 12 times yearly by the Cleveland Clinic Foundation.

Subscription rates: U.S. and possessions: personal $98; institutional $124; single copy/back issue $16. Foreign: $124; single copy/back issue $16. Institutional (multiple-reader rate) applies to libraries, schools, hospitals, and federal, commercial, and private institutions and organizations. Individual subscriptions must be in the names of, billed to, and paid by individuals.

Postmaster address changes: Cleveland Clinic Journal of Medicine, NA32, 9500 Euclid Avenue, Cleveland, OH 44195. Subscription orders, editorial, reprint, and production offices (same address): Phone: (216) 444-2661; Fax: (216) 444-9385; E-mail: ccjm@ccf.org; World Wide Web: http://www.ccjm.org

Printed in USA.